Edwards Lifesciences Appoints Doretta Mistras as New Chief Financial Officer

Key Facts

Edwards Lifesciences has officially named Doretta Mistras as its corporate vice president and chief financial officer, effective at the end of May. Mistras succeeds Scott Ullem following a planned transition period, bringing extensive experience in financial planning, reporting, and investment banking to the role. She joins the medical technology firm from Viatris, where she previously served as CFO. Analysts have reacted positively to the appointment, expecting it to maintain stability in the company's financial outlook. This strategic move completes a leadership succession aimed at ensuring continuity in financial operations. Mistras's diverse background in finance and healthcare is expected to bolster the company's long-term growth initiatives and market position.

Version History